You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MERTK (mer proto-oncogene tyrosine kinase)

Showing 1 - 25 of 2,302
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Mar 8, 2022

Tumor Metastasis Trial in Worldwide (PF-07265807, Sasanlimab, Axitinib)

Recruiting
  • Neoplasm Metastasis
  • Fayetteville, Arkansas
  • +33 more
Aug 20, 2022

MERTK Signalling in Monocytes/Macrophages in Liver Disease

Recruiting
  • Liver Disease
  • +3 more
  • blood sampling for research purpose
  • +3 more
  • Basel, Switzerland
  • +3 more
Nov 17, 2021

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)

Recruiting
  • BRAF V600E
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +33 more
Dec 20, 2022

Resistance-associated Mutations in Metastatic Lung Cancer

Recruiting
  • Lung Cancer
  • Liquid biopsy
  • Monza, MB, Italy
    Fondazione IRCCS San Gerardo dei Tintori
Oct 10, 2023

Mer-TK in Human Cardiac Cells

Completed
  • Myocardial Inflammation
  • Myocardial Infarction
  • Change in Soluble MER Concentration
  • Chicago, Illinois
    Ann & Robert H Lurie Children's Hopsital
Aug 10, 2021

NSCLC Metastatic, Targetable Oncogenes (EGFR, ALK, ROS1) Trial in Boston (SBRT with protons or photons)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Targetable Oncogenes (EGFR, ALK, ROS1)
  • SBRT with protons or photons
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 22, 2021

Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma Trial in United States

Active, not recruiting
  • Stage III Cutaneous Melanoma AJCC v7
  • +2 more
  • Computed Tomography
  • +3 more
  • Birmingham, Alabama
  • +759 more
Aug 18, 2022

Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic Trial in Canada, United States (SLC-391, Pembrolizumab)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • +2 more
  • Indianapolis, Indiana
  • +8 more
May 5, 2023

BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma Trial in Guangzhou (Encorafenib)

Completed
  • BRAF V600E Unresectable or Metastatic Melanoma
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 9, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Biospecimen Collection
  • +4 more
  • Birmingham, Alabama
  • +170 more
Jan 30, 2023

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Los Angeles, California
  • +28 more
Dec 1, 2021

Metastatic Sporadic Medullary Thyroid Cancer Patients and

Completed
  • Metastatic Sporadic Medullary Thyroid Cancer
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
    Sep 29, 2021

    Biliary Tract Carcinoma Trial in Shanghai (Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab)

    Recruiting
    • Biliary Tract Carcinoma
    • Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Dec 25, 2022

    Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Worldwide (procedure,

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +15 more
    • Birmingham, Alabama
    • +550 more
    Jan 28, 2023

    Diffuse Large B-cell Lymphoma(DLBCL) Trial in Shanghai (Zanubrutinib + R-CHOP)

    Recruiting
    • Diffuse Large B-cell Lymphoma(DLBCL)
    • Zanubrutinib + R-CHOP
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Feb 10, 2022

    Hepatocellular Carcinoma Trial in Chicago (Atezolizumab and Bevacizumab, Y90 + TKI)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Atezolizumab and Bevacizumab
    • Y90 + TKI
    • Chicago, Illinois
      Northwestern University
    Nov 11, 2022

    Psoriasis Vulgaris Trial in San Francisco (deucravacitinib)

    Not yet recruiting
    • Psoriasis Vulgaris
    • San Francisco, California
      University of California, San Francisco
    May 4, 2023

    Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Circulating Tumor Cell Trial in Montpellier (Detection of

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +2 more
    • Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
    • Montpellier, France
      CHU Montpellier
    Jul 1, 2022

    Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI

    Recruiting
    • Non-Small Cell Carcinoma of Lung, TNM Stage 4
    • +5 more
      • Aurora, Colorado
        University of Colorado, Cancer Center
      Nov 3, 2021

      Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

      Active, not recruiting
      • Low-grade Glioma
      • +2 more
      • Calgary, Alberta, Canada
      • +6 more
      Oct 25, 2022

      Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      Nov 28, 2022

      Atypical Carcinoid Tumor, Carcinoid Tumor, Functioning Pancreatic Neuroendocrine Tumor Trial in United States (Cabozantinib

      Recruiting
      • Atypical Carcinoid Tumor
      • +18 more
      • Cabozantinib S-malate
      • +3 more
      • Anchorage, Alaska
      • +425 more
      Aug 12, 2022

      Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)

      Active, not recruiting
      • Liposarcoma
      • Metastatic Liposarcoma
      • Boston, Massachusetts
      • +2 more
      Nov 23, 2022